Citations

Clear

14 citation(s) found for "Garfall, Alfred L".

MonumenTAL-5: A Phase 3 Study of Talquetamab Versus Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma Who Received ≥4 Prior Lines of Therapy, Including a Proteasome Inhibitor, an Immunomodulatory Drug, and an Anti-CD38 Monoclonal A
Kumar, Shaji , Trudel, Suzanne , Ma, Xuewen, Olyslager, Yunsi, Thakkar, Payal, Pei, Lixia, Heuck, Christoph, Garfall, Alfred L. , Ocio, Enrique M. , Scott, Emma , Huang, Lin , Terpos, Evangelos

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7292-7293

10.1182/blood-2022-163260 Get It

NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022
Adekola, Kehinde , Anderson, Larry D. , Costello, Caitlin , Elsedawy, Noura, Faiman, Matthew , Godby, Kelly, Hillengaß, Jens , Holmberg, Leona , Htut, Myo , Huff, Carol Ann , Hultcrantz, Malin , Larson, Sarah , Liedtke, Michaela , Omel, James, Sborov, Douglas W. , Shain, Kenneth H. , Weber, Donna, Berardi, Ryan A., Kumar, Shaji , Holmberg, Leona , Anderson, Larry D , Callander, Natalie S. , Baljević, Muhamed , Campagnaro, Erica , Castillo, Jorge J. , Devarakonda, Srinivas , Garfall, Alfred L. , Kang, Yubin , Martin, Thomas G. , Stockerl‐Goldstein, Keith , Kumar, Rashmi

Mayo Clinic

Journal of the National Comprehensive Cancer Network | January 28, 2022 | Volume: 20 | Issue: 1 | Pages: 8-19

10.6004/jnccn.2022.0002 | PMID 34991075 Get It

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, initial workup, treatment, follow-up, and supportive care for patients with various plasma cell neoplasms, including multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates/changes specific to the treatment of patients with multiple myeloma in the 2022 version of the guidelines.
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Kumar, Shaji , Adekola, Kehinde , Anderson, Larry D. , Castillo, Jorge J. , Chandler, Jason C., Costello, Caitlin , Efebera, Yvonne A. , Faiman, Matthew , Garfall, Alfred L. , Godby, Kelly, Hillengaß, Jens , Holmberg, Leona , Htut, Myo , Huff, Carol Ann , Hultcrantz, Malin , Larson, Sarah , Liedtke, Michaela , Omel, James, Shain, Kenneth H. , Sborov, Douglas W. , Stockerl‐Goldstein, Keith , Weber, Donna, Keller, Jennifer , Holmberg, Leona , Castillo, Jorge J , Anderson, Larry D , Garfall, Alfred L , Callander, Natalie S. , Baljević, Muhamed , Campagnaro, Erica , Kang, Yubin , Martin, Thomas G. , Kumar, Rashmi , Stockerl-Goldstein, Keith

Mayo Clinic

Journal of the National Comprehensive Cancer Network | December 7, 2020 | Volume: 18 | Issue: 12 | Pages: 1685-1717

10.6004/jnccn.2020.0057 | PMID 33285522 Get It

Multiple myeloma is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. This manuscript discusses the management of patients with solitary plasmacytoma, smoldering multiple myeloma, and newly diagnosed multiple myeloma.
NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020
Kumar, Shaji , Hillengaß, Jens , Liedtke, Michaela , Campagnaro, Erica , Chandler, Jason C., Cornell, Robert F. , Costello, Caitlin , Efebera, Yvonne A. , Faiman, Matthew , Garfall, Alfred L. , Godby, Kelly, Holmberg, Leona , Htut, Myo , Huff, Carol Ann , Malek, Ehsan , Omel, James, Sborov, Douglas W. , Stockerl‐Goldstein, Keith , Tan, Carlyn , Weber, Donna, Johnson-Chilla, Alyse, Keller, Jennifer , Holmberg, Leona , Callander, Natalie S. , Baljević, Muhamed , Castillo, Jorge J. , Kang, Yubin , Landgren, Ola , Martin, Thomas G. , Raje, Noopur , Singhal, Seema , Kumar, Rashmi , Garfall, Alfred L , Campagnaro, Erica L , Stockerl-Goldstein, Keith

Mayo Clinic

Journal of the National Comprehensive Cancer Network | October 7, 2019 | Volume: 17 | Issue: 10 | Pages: 1154-1165

10.6004/jnccn.2019.0049 | PMID 31590151 Get It

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates and changes in the 1.2020 version of the NCCN Guidelines for Multiple Myeloma.